COO
Price
$101.46
Change
-$0.38 (-0.37%)
Updated
Mar 28, 6:59 PM EST
63 days until earnings call
MDT
Price
$87.13
Change
+$0.18 (+0.21%)
Updated
Mar 28, 6:59 PM EST
56 days until earnings call
Ad is loading...

Compare predictions COO vs MDT

Header iconCOO vs MDT Comparison
Open Charts COO vs MDTBanner chart's image
Cooper Companies (The)
Price$101.46
Change-$0.38 (-0.37%)
Volume$439.5K
CapitalizationN/A
Medtronic
Price$87.13
Change+$0.18 (+0.21%)
Volume$1.84M
CapitalizationN/A
View a ticker or compare two or three
COO vs MDT Comparison Chart

Loading...

COODaily Signal changed days agoGain/Loss if shorted
 
Show more...
MDTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
COO vs. MDT commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COO is a StrongSell and MDT is a StrongBuy.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (COO: $101.46 vs. MDT: $87.13)
Brand notoriety: COO: Not notable vs. MDT: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: COO: 51% vs. MDT: 30%
Market capitalization -- COO: $20.25B vs. MDT: $115.41B
COO [@Medical Specialties] is valued at $20.25B. MDT’s [@Medical Specialties] market capitalization is $115.41B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COO’s FA Score shows that 1 FA rating(s) are green whileMDT’s FA Score has 1 green FA rating(s).

  • COO’s FA Score: 1 green, 4 red.
  • MDT’s FA Score: 1 green, 4 red.
According to our system of comparison, COO is a better buy in the long-term than MDT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COO’s TA Score shows that 3 TA indicator(s) are bullish while MDT’s TA Score has 4 bullish TA indicator(s).

  • COO’s TA Score: 3 bullish, 6 bearish.
  • MDT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, MDT is a better buy in the short-term than COO.

Price Growth

COO (@Medical Specialties) experienced а +0.09% price change this week, while MDT (@Medical Specialties) price change was +4.46% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.79%. For the same industry, the average monthly price growth was -0.28%, and the average quarterly price growth was +4.33%.

Reported Earning Dates

COO is expected to report earnings on May 30, 2024.

MDT is expected to report earnings on May 23, 2024.

Industries' Descriptions

@Medical Specialties (+0.79% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for COO with price predictions.
OPEN
A.I.dvisor published
a Summary for MDT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MDT($115B) has a higher market cap than COO($20.3B). COO has higher P/E ratio than MDT: COO (69.91) vs MDT (27.59). COO YTD gains are higher at: 7.240 vs. MDT (6.641). MDT has higher annual earnings (EBITDA): 8.91B vs. COO (895M). MDT has more cash in the bank: 8.32B vs. COO (135M). COO has less debt than MDT: COO (2.77B) vs MDT (25.2B). MDT has higher revenues than COO: MDT (32.3B) vs COO (3.67B).
COOMDTCOO / MDT
Capitalization20.3B115B18%
EBITDA895M8.91B10%
Gain YTD7.2406.641109%
P/E Ratio69.9127.59253%
Revenue3.67B32.3B11%
Total Cash135M8.32B2%
Total Debt2.77B25.2B11%
FUNDAMENTALS RATINGS
COO vs MDT: Fundamental Ratings
COO
MDT
OUTLOOK RATING
1..100
8419
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
5081
SMR RATING
1..100
8678
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
2659
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MDT's Valuation (4) in the Medical Specialties industry is significantly better than the same rating for COO (91). This means that MDT’s stock grew significantly faster than COO’s over the last 12 months.

COO's Profit vs Risk Rating (50) in the Medical Specialties industry is in the same range as MDT (81). This means that COO’s stock grew similarly to MDT’s over the last 12 months.

MDT's SMR Rating (78) in the Medical Specialties industry is in the same range as COO (86). This means that MDT’s stock grew similarly to COO’s over the last 12 months.

MDT's Price Growth Rating (50) in the Medical Specialties industry is in the same range as COO (50). This means that MDT’s stock grew similarly to COO’s over the last 12 months.

COO's P/E Growth Rating (26) in the Medical Specialties industry is somewhat better than the same rating for MDT (59). This means that COO’s stock grew somewhat faster than MDT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COOMDT
RSI
ODDS (%)
Bearish Trend 1 day ago
62%
Bearish Trend 1 day ago
31%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
42%
Momentum
ODDS (%)
Bearish Trend 1 day ago
54%
Bullish Trend 1 day ago
60%
MACD
ODDS (%)
Bearish Trend 1 day ago
50%
Bullish Trend 1 day ago
41%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
53%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
54%
Advances
ODDS (%)
Bullish Trend 10 days ago
63%
Bullish Trend 1 day ago
50%
Declines
ODDS (%)
Bearish Trend 7 days ago
53%
Bearish Trend 14 days ago
51%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
36%
Aroon
ODDS (%)
Bearish Trend 7 days ago
54%
Bearish Trend 1 day ago
52%
View a ticker or compare two or three
Ad is loading...
COODaily Signal changed days agoGain/Loss if shorted
 
Show more...
MDTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VICI29.760.01
+0.03%
VICI Properties
GLTO0.78N/A
N/A
Galecto
TDC38.66-0.71
-1.80%
TERADATA Corp
GTHX4.32-0.15
-3.36%
G1 Therapeutics
AZUL7.77-0.76
-8.91%
Azul SA